FDA Pediatric Written Request

Advertisement

cGxPJobs Banner

Neurocrine Initiates Phase 2 Trial of Crinecerfont in Children Under 4 with Classic CAH

SAN DIEGO, July 1, 2026 Neurocrine Biosciences announced the initiation of a Phase 2 clinical trial evaluating crinecerfont (CRENESSITY®)...

By cGxPwire Editor
July 2, 2026

Read More

Advertisement

cGxPJobs

Directory